Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells

European Journal of Nutrition

Volumn 52, Issue 2, 2013, Pages 505-512

  Lechowski, Sandra ^a   Feilhauer, Katharina ^b   Staib, Ludger ^c   Coëffier, Moïse ^d   Bischoff, Stephan C ^a   Lorentz, Axel ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b KATHARINENHOSPITAL   (Germany)

^c KLINIKUM ESSLINGEN   (Germany)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

Arginine; Cytokine expression; Glutamine; Intestinal mucosa; Mast cell

Indexed keywords

ARGININE; BETA N ACETYLHEXOSAMINIDASE; CYTOKINE; GLUTAMINE; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 8; LEUKOTRIENE; LEUKOTRIENE C4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; DRUG MECHANISM; ENZYMATIC ASSAY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; MAST CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARGININE; BETA-N-ACETYLHEXOSAMINIDASES; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL4; CYTOKINES; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GLUTAMINE; HUMANS; INTERLEUKIN-8; INTESTINES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKOTRIENE C4; MALE; MAST CELLS; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 84879556322     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0353-1     Document Type: Article

References (42)

1. Nieves C Jr, Langkamp-Henken B (2002) Arginine and immunity: a unique perspective. Biomed Pharmacother 56:471-482
2. Powell-Tuck J (2007) Nutritional interventions in critical illness. Proc Nutr Soc 66:16-24
3. Lecleire S, Hassan A, Marion-Letellier R, Antonietti M, Savoye G, Bole-Feysot C, Lerebours E, Ducrotte P, Dechelotte P, Coeffier M (2008) Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J Nutr 138:2481-2486
4. Kolios G, Valatas V, Ward SG (2004) Nitric oxide in inflammatory bowel disease, a universal messenger in an unsolved puzzle. Immunology 113:427-437
5. Suchner U, Heyland DK, Peter K (2002) Immune-modulatory actions of arginine in the critically ill. Br J Nutr 87(Suppl 1):121-132
6. Coeffier M, Marion-Letellier R, Dechelotte P (2010) Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm Bowel Dis 16:518-524
7. Chang WK, Yang KD, Chuang H, Jan JT, Shaio MF (2002) Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol 104:151-160
8. Wischmeyer PE, Riehm J, Singleton KD, Ren H, Musch MW, Kahana M, Chang EB (2003) Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 19:1-6
9. Fukatsu K, Kudsk KA, Zarzaur BL, Wu Y, Hanna MK, DeWitt RC (2001) TPN decreases IL-4 and IL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression. Shock 15:318-322
10. Horio Y, Osawa S, Takagaki K, Hishida A, Furuta T, Ikuma M (2008) Glutamine supplementation increases Th1-cytokine responses in murine intestinal intraepithelial lymphocytes. Cytokine 44:92-95
11. Boelens PG, Houdijk AP, Fonk JC, Nijveldt RJ, Ferwerda CC, Von Blomberg-Van Der Flier BM, Thijs LG, Haarman HJ, Puyana JC, Van Leeuwen PA (2002) Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 132:2580-2586
12. Wells SM, Kew S, Yaqoob P, Wallace FA, Calder PC (1999) Dietary glutamine enhances cytokine production by murine macrophages. Nutrition 15:881-884
13. Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, Gonzalez-Gallego J, Tunon MJ (2008) Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis 14:1504-1513
14. Coeffier M, Marion R, Leplingard A, Lerebours E, Ducrotte P, Dechelotte P (2002) Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e(2) production by human gut in vitro. Cytokine 18:92-97
15. Coeffier M, Marion R, Ducrotte P, Dechelotte P (2003) Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr 22:407-413
16. Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells, negative, as well as positive, regulators of immunity. Nat Rev Immunol 8:478-486
17. Bischoff SC (2009) Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 31:185-205
18. Rijnierse A, Nijkamp FP, Kraneveld AD (2007) Mast cells and nerves tickle in the tummy, implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther 116:207-235
19. He SH (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10:309-318
20. Lilja I, Gustafson-Svard C, Franzen L, Sjodahl R (2000) Tumor necrosis factor-alpha in ileal mast cells in patients with Crohn's disease. Digestion 61:68-76
21. Sellge G, Bischoff SC (2006) Isolation, culture, and characterization of intestinal mast cells. Methods Mol Biol 315:123-138
22. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP (1999) IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A 96:8080-8085
23. Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC (2000) Human intestinal mast cells are capable of producing different cytokine profiles, role of IgE receptor cross-linking and IL-4. J Immunol 164:43-48
24. Thienemann F, Henz BM, Babina M (2004) Regulation of mast cell characteristics by cytokines, divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 296:134-138
25. Marion R, Coëffier MM, Gargala G, Ducrotté P, Déchelotte PP (2004) Glutamine and CXC chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells. Clin Nutr 23:579-585
26. Marion R, Coeffier M, Lemoulan S, Gargala G, Ducrotte P, Dechelotte P (2005) l-Arginine modulates CXC chemokines in the human intestinal epithelial cell line HCT-8 by the NO pathway. Biochimie 87:1048-1055
27. Lecleire S, Coeffier M, Leblond J, Hubert A, Lemoulan S, Petit A, Ducrotte P, Dechelotte P, Marion R (2005) Modulation of nitric oxide and cytokines production by l-arginine in human gut mucosa. Clin Nutr 24:353-359
28. Schwartz LB, Austen KF, Wasserman SI (1979) Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J Immunol 123:1445-1450
29. Feuser K, Feilhauer K, Staib L, Bischoff SC, Lorentz A (2011) Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells. Mol Immunol 48:546-552
30. Lorentz A, Wilke M, Sellge G, Worthmann H, Klempnauer J, Manns MP, Bischoff SC (2005) IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 174:6751-6756
31. Hubert-Buron A, Leblond J, Jacquot A, Ducrotte P, Dechelotte P, Coeffier M (2006) Glutamine pretreatment reduces IL-8 production in human intestinal epithelial cells by limiting IkappaBalpha ubiquitination. J Nutr 136:1461-1465
32. Mañé J, Fernández-Bañares F, Ojanguren I, Castellá E, Bertrán X, Bartolí R, Alvarez M, Gassull MA (2001) Effect of l-arginine on the course of experimental colitis. Clin Nutr 20:415-422
33. Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S (2002) p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 168:5342-5351
34. Lockyer HM, Tran E, Nelson BH (2007) STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. J Immunol 179:5301-5308
35. Ruiz PA, Haller D (2006) Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J Nutr 136:664-671
36. Giris M, Erbil Y, Dogru-Abbasoglu S, Yanik BT, Alis H, Olgac V, Toker GA (2007) The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis. Int J Colorectal Dis 22:591-599
37. Coskun M, Olsen J, Seidelin JB, Nielsen OH (2011) MAP kinases in inflammatory bowel disease. Clin Chim Acta 412:513-520
38. Neurath MF, Fuss I, Schurmann G, et al. (1998) Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci 859:149-159
39. Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A, Kuhbacher T, Hamling J, Folsch UR, Seegert D (2002) Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 51:379-385
40. Mudter J, Neurath MF (2007) IL-6 signaling in inflammatory bowel disease, pathophysiological role and clinical relevance. Inflamm Bowel Dis 13:1016-1023
41. Levy DE, Darnell JE Jr (2002) Stats, transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662
42. Koon HW, Zhao D, Zhan Y, Rhee SH, Moyer MP, Pothoulakis C (2006) Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells. J Immunol 176:5050-5059